Literature DB >> 1718163

Serum response heterogeneity among nonsmall cell lung cancer cell lines.

K T Goldsmith1, C M Listinsky, R I Garver.   

Abstract

This study examined the morphology, in vitro growth, and two genetic responses to serum stimulation in the nonsmall cell lung cancer (NSCLC) cell lines SK-Lu-1, SK-MES-1, A427, and A549. Morphologically, all four were NSCLC: SK-Lu-1 was undifferentiated, the remainder were adenocarcinoma variants. SK-Lu-1 and SK-MES-1 were slow growing with low-anchorage independent growth capacity; the A427 and A549 lines were fast growing with high-anchorage independent growth capacity. All of the lines expressed basic fibroblast growth factor (bFGF) as a dominant 7.1 kb transcript at amounts significantly lower than in control human lung fibroblasts. bFGF expression could be upregulated by serum exposure in several nontransformed human cell lines, but only the SK-Lu-1 NSCLC cells increased bFGF after serum exposure (482%) compared with a peak increase of 1222% in the fibroblast controls. All of the NSCLC cell lines increased c-fos in response to the same serum stimulations. These results show that growth-factor gene expression can be modulated in NSCLC, and that significant differences exist among NSCLC cell lines commonly used as laboratory correlates of human disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718163      PMCID: PMC1886311     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Characterization of the HST-related FGF.6 gene, a new member of the fibroblast growth factor gene family.

Authors:  I Marics; J Adelaide; F Raybaud; M G Mattei; F Coulier; J Planche; O de Lapeyriere; D Birnbaum
Journal:  Oncogene       Date:  1989-03       Impact factor: 9.867

2.  Expression of multiple growth factors in a human lung cancer cell line.

Authors:  C Betsholtz; J Bergh; M Bywater; M Pettersson; A Johnsson; C H Heldin; R Ohlsson; T J Knott; J Scott; G I Bell
Journal:  Int J Cancer       Date:  1987-04-15       Impact factor: 7.396

3.  Inhibition of growth of human lung adenocarcinoma cell lines by anti-transforming growth factor-alpha monoclonal antibody.

Authors:  K Imanishi; K Yamaguchi; M Kuranami; E Kyo; T Hozumi; K Abe
Journal:  J Natl Cancer Inst       Date:  1989-02-01       Impact factor: 13.506

4.  Type beta transforming growth factor: a bifunctional regulator of cellular growth.

Authors:  A B Roberts; M A Anzano; L M Wakefield; N S Roche; D F Stern; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells.

Authors:  M Lieber; B Smith; A Szakal; W Nelson-Rees; G Todaro
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

6.  Copurification of osteolytic and transforming growth factor beta activities produced by human lung tumor cells associated with humoral hypercalcemia of malignancy.

Authors:  T A Linkhart; S Mohan; J C Jennings; D J Baylink
Journal:  Cancer Res       Date:  1989-01-15       Impact factor: 12.701

7.  Differential expression of mRNA coding for heparin-binding growth factor type 2 in human cells.

Authors:  M D Sternfeld; J E Hendrickson; W W Keeble; J T Rosenbaum; J E Robertson; M R Pittelkow; G D Shipley
Journal:  J Cell Physiol       Date:  1988-08       Impact factor: 6.384

8.  Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors.

Authors:  R Derynck; D V Goeddel; A Ullrich; J U Gutterman; R D Williams; T S Bringman; W H Berger
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

9.  Biological effect of epidermal growth factor on the in vitro growth of human tumors.

Authors:  S E Singletary; F L Baker; G Spitzer; S L Tucker; B Tomasovic; W A Brock; J A Ajani; A M Kelly
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

10.  An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family.

Authors:  P Delli Bovi; A M Curatola; F G Kern; A Greco; M Ittmann; C Basilico
Journal:  Cell       Date:  1987-08-28       Impact factor: 41.582

View more
  1 in total

Review 1.  Pulmonary toxicity of e-cigarettes.

Authors:  Lauren F Chun; Farzad Moazed; Carolyn S Calfee; Michael A Matthay; Jeffrey E Gotts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-18       Impact factor: 5.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.